http://www.reportbuyer.com/rss.htmlKeep up with industry trends and gain a competitive advantage in the Pain market. Find information on Pain Management, Therapeutics and Analysis.en-gbReportbuyerservice@reportbuyer.comenquiries@redwiredesign.comhttp://www.reportbuyer.com/pharma_healthcare/diseases/pain/vaccines_market_outlook_2014.htmlReport Overview A combination of new biotechnology research techniques and manufacturing technologies has reinvigorated the global vaccines industry. Vaccines are now targeting larger markets following increasing demand and improved profitability. The WHO estimates that more than 75 vaccines are currently at various stages of development for a range of diseases including AIDs, diarrhoea, pneumococcal disease, cervical cancer and smoking. eb3a052d650d0be6316cbefc689ce3acTue, 07 Jul 2009 12:00:00 GBDiseases/Painhttp://www.reportbuyer.com/pharma_healthcare/diseases/pain/global_spine_market_report_2009_edition.htmlSpinal implant market, one of the largest markets in orthopedics, is being driven by favorable demographic trends and high incidence of back pain. In the US, the occurrence of lower back pain at some time in one's lifetime is almost ninety percent. Technological advances such as minimal invasive procedures and non-fusion technologies, are also aiding in growth of the market. bd0a1d0d168dcf178bb8fe378a985c91Mon, 02 Feb 2009 12:00:00 GBDiseases/Painhttp://www.reportbuyer.com/pharma_healthcare/diseases/pain/global_pain_market_2008_2023.htmlThe global pain market generated total sales of $34bn in 2007 - but what will the figures be in the next 5 and 10 years? This report tells you. The pain market has marked strengths and advantages, but is also limited by problems and concerns. The market will be driven by new drugs and reformulations of existing ones - but which drugs will be most successful? The incidence of pain is increasing rapidly, what some experts call a pain epidemic - so the opportunities available to an additional blockbuster drug is significant. cc63db975ff6bd6247ccba48381352fbTue, 11 Nov 2008 12:00:00 GBDiseases/Painhttp://www.reportbuyer.com/pharma_healthcare/diseases/pain/pain_management.htmlThis report analyzes the worldwide markets for Pain Management in Millions of US$. The specific product segments analyzed are Pain Management Pharmaceuticals, Pain Management Devices, and Pain Management Services. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. 6377b0d262109f45d7efed4d770e4963Mon, 03 Mar 2008 12:00:00 GBDiseases/Painhttp://www.reportbuyer.com/pharma_healthcare/diseases/pain/peripheral_neuropathy_neuropathic_pain_2008.htmlThis report estimates that Peripheral Neuropathy (PN) and Neuropathic Pain (NP) affect 170 to 270 million individuals globally. PN and NP are causally linked to a number of diseases, however diabetes, cancer and HIV alone are expected to increase the prevalence of PN and NP by more than 10% by 2012. PN and NP are areas of significant and critical unmet need. 473639da5c2885a4e22098082ac22480Tue, 01 Jan 2008 12:00:00 GBDiseases/Painhttp://www.reportbuyer.com/pharma_healthcare/diseases/pain/global_pain_pharmaceutical_market_analysis_forecasts_2007_2022.htmlPlease Note: Reports are sold based on the user licenses indicated. The reports will be accessible in Flash format via an online reading room on the publisher website, allowing viewing and printing capabilities only. Within one to two business days after placing the order,the client will receive an email with information on accessing their purchase. 8f7eef770ce26bc8e5a2ccab486efde1Thu, 27 Sep 2007 12:00:00 GBDiseases/Painhttp://www.reportbuyer.com/pharma_healthcare/diseases/pain/global_market_pain_management_drugs_devices.htmlThe goal of BCC Research in conducting this study was to determine the present status of the worldwide pain-management market and also to evaluate its potential over the five-year period from 2007 to 2012. The pain-management market has been analyzed considering two main segments: pharmaceuticals and devices. The pharmaceuticals segment is further subdivided into different types, such as non-opioids, opioids, anticonvulsants, and antidepressants, whereas the medical devices segments is segmented into transcutaneous electrical nerve stimulation (TENS), spinal cord stimulator (SCS) and peripheral nerve stimulator (PNS), and intrathecal pumps. a2ddb57c7ec5d43b68e9a919e17f1b80Sat, 06 Jan 2007 12:00:00 GBDiseases/Painhttp://www.reportbuyer.com/pharma_healthcare/diseases/pain/world_market_pain_management_drugs_devices.htmlThis Kalorama Information report focuses on current and emerging immunomodulators for cancer. The report covers both current and emerging cancer immunomodulators in detail. The report includes statistical information for cancers by type worldwide, with special emphasis on the U. 6ea540607cede8de7d2eaf1fda029902Tue, 12 Dec 2006 12:00:00 GBDiseases/Painhttp://www.reportbuyer.com/pharma_healthcare/diseases/pain/pain_therapeutics_2005.htmlPain Therapeutics 2005: Market Dynamics and Outlook provides detailed analysis and information concerning the global market for pain therapeutics, R&D pipelines and company involvement in this field. About one and a half billion people suffer from moderate to severe chronic pain worldwide and approximately 50 million Americans suffer with pain. The value of the pharmaceutical market for pain relief reflects this seeming worldwide epidemic of pain, with the overall value reaching nearly $23 billion in 2004. d75a2e155615bcd8822c6b8eea3edbe2Sat, 14 May 2005 12:00:00 GBDiseases/Pain